Evidence map›Paper›PMID 39587981›Full record

ArticleJournal of neuroendocrinology2025

Screening and surveillance practices for Multiple Endocrine Neoplasia type 1-related Neuroendocrine Tumours in European Neuroendocrine Tumor Society Centers of Excellence (ENETS CoE)-An ENETS MEN1 task force questionnaire study.

Carolina R C Pieterman, Simona Grozinsky-Glasberg, Dermot O'Toole, James R Howe, Valentina Ambrosini, Susana H Belli, Mikkel Andreassen, Nehara Begum, Timm Denecke, Antongiulio Faggiano and 19 more

Abstract read
In one paragraph

Article in Journal of neuroendocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Carolina R C PietermanDepartment of Endocrine Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.ORCID 0000-0003-4894-373X
Simona Grozinsky-GlasbergNeuroendocrine Unit, ENETS Center of Excellence, Division of Medicine, Hadassah Medical Center and Faculty of Medicine, The Hebrew University, Jerusalem, Israel.ORCID 0000-0002-1014-9154
Dermot O'TooleDepartment of Clinical Medicine, St James Hospital, Trinity College Dublin & National Centre for Neuroendocrine Tumours, St Vincent's University Hospital, Dublin, Ireland.ORCID 0000-0001-6404-991X
James R HoweUniversity of Iowa Carver College of Medicine, Iowa City, Iowa, USA.ORCID 0000-0001-5312-5972
Valentina AmbrosiniNuclear Medicine, Alma Mater Studiorum, University of Bologna, Bologna, Italy.ORCID 0000-0002-5008-5351
Susana H BelliEndocrinology Instituto Alexander Fleming, Buenos Aires, Argentina.
Mikkel AndreassenDepartment of Endocrinologt, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0002-1656-3516
Nehara BegumDepartment of General-, Visceral-, Thoracic- and Endocrine Surgery, Johannes Wesling Klinikum Minden, University Hospital of the Ruhr-University Bochum (RUB), Minden, Germany.ORCID 0000-0002-7866-0776
Timm DeneckeKlinik für Diagnostische und Interventionelle Radiologie, Universitätsklinikum Leipzig, Leipzig, Germany.ORCID 0000-0003-3313-3208
Antongiulio FaggianoEndocrinology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, ENETS Center of Excellence, Sapienza University of Rome, Rome, Italy.ORCID 0000-0002-9324-3946
Massimo FalconiPancreatic and Transplantation Surgical Unit, IRCCS San Raffaele Hospital, Università Vita-Salute, Milan, Italy.ORCID 0000-0001-9654-7243
Jo GreyAMEND (Association for Multiple Endocrine Neoplasia Disorder), Tornbridge, UK.
Ulrich P KniggeDepartment of Endocrinology and Department of Surgery and Transplantation, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0001-5930-0903
Teodora KolarovaExecutive Director International Neuroendocrine Cancer Alliance (INCA), Boston, Massachusetts, USA.
Bruno NiederleDivision of Visceral Surgery, Department of General Surgery, Medical University, Vienna, Austria.ORCID 0000-0001-8107-4068
Els Nieveen van DijkumDepartment of Surgery, Cancer Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-3029-6071
Stefano PartelliVita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy.ORCID 0000-0001-8938-6170
Andreas PascherKlinik für Allgemein-, Viszeral- und Transplantationschirurgie, Universitätsklinikum Münster, Münster, Germany.
Guido RindiDepartment of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.ORCID 0000-0003-2996-4404
Philippe RuszniewskiUniversité de Paris, Beaujon Hospital, Clichy, France.
Stefan StättnerDepartment of General, Visceral and Vascular Surgery, Salzkammergut Klinikum Vöcklabruck, Oberösterreichische Gesundheitsholding OÖG, Vöcklabruck, Austria.ORCID 0000-0002-5226-7597
Timon VandammeNETwerk, Department of Oncology, Antwerp University Hospital, Antwerp, Belgium.ORCID 0000-0003-3701-5305
Juan W ValleDivision of Cancer Sciences, University of Manchester, Manchester, UK.ORCID 0000-0002-1999-0863
Marie-Pierre VulliermeUniversité Paris Diderot, Paris, France.ORCID 0000-0002-3667-8943
Staffan WelinEndocrine Oncology, Department of Medical sciences Uppsala University, Uppsala, Sweden.
Aurel PerrenInstitute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland.ORCID 0000-0002-6819-6092
Detlef K BartschDepartment of Visceral-, Thoracic and Vascular Surgery, Philipps-University Marburg, Marburg, Germany.ORCID 0000-0003-1608-2496
Gregory K Kaltsas1st Propaedeutic Department of Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.ORCID 0000-0002-5876-7883
Gerlof D ValkDepartment of Endocrine Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.ORCID 0000-0001-5841-8344

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple Endocrine Neoplasia type 1 (MEN1) Clinical Practice Guidelines (2012) are predominantly based on expert opinion due to limited available evidence at the time, leaving room for interpretation and variation in practices. Evidence on the natural course of MEN1-related neuroendocrine tumours (NET) and the value of screening programs has increased and new imaging techniques have emerged. The aim of this study is to provide insight in the current practices of screening and surveillance for MEN1-related NETs in ENETS Centers of Excellence (CoEs). A clinical practice questionnaire was distributed among all 65 ENETS CoEs. Response rate was 91% (59/65). In 14% of CoEs <10 patients, in 50% 10-49, in 31% 50-100 and in 3 centres (5%) >100 patients with MEN1 are seen. Practices with regard to screening and surveillance of NETs were markedly heterogeneous. Differences between countries were noted in the use of gut hormones for biochemical screening and the choice for imaging modality for screening/surveillance of pancreatic NETs (PanNETs). Magnetic resonance imaging (MRI) is the preferred modality for screening and surveillance of PanNETs, whereas this is computed tomography (CT) for thoracic NETs. Practices regarding screening for thoracic NETs were more homogeneous among larger volume CoEs, with longer screening intervals. The majority of CoEs tailored the surveillance of small pancreatic and lung NETs to observed growth rate. 68% of CoEs advise patients with clinical MEN1 with negative genetic testing to undergo periodic screening like mutation-positive patients. In conclusion, there is still marked heterogeneity in practice, although there are also common trends. Differences were sometimes associated with volume or country, but often no association was found. This underscores the need for clear and evidence-based practice recommendations.

Indexed as

Early Detection of CancerMultiple Endocrine Neoplasia Type 1Neuroendocrine TumorsEuropeFemaleHumansMaleMass ScreeningSurveys and Questionnairesmultiple endocrine neoplasia type 1neuroendocrine tumourscreeningsurveillancesurvey

Identifiers

PMID39587981
PMCPMC11750319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.